ABT-333 074 several Saccharomyces cerevisiae mutants were

several Saccharomyces cerevisiae mutants were screened and tested

K562 and primary cells) treatment induces K562 or primary cells apoptosis in an concentration dependent manner

the kind of fruit produced by citrus trees

(−)-Sphingosine

23)/t14-/m0/s1

ABT-333 074 several Saccharomyces cerevisiae mutants wereDasabuvir, also known as ABT 333, is a non nucleoside polymerase inhibitor currently under clinical trials for the treatment of Hepatitis C. In the United States, it is approved by the Food and Drug Administration for use in combination with ombitasvir, paritaprevir, and ritonavir in the product Viekira Pak. Dasabuvir acts as a NS5B (an RNA directed RNA polymerase) inhibitor. Product information CAS Number: 1132935 63 7 Molecular Weight: 493. 57